Literature DB >> 12223450

Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness.

Heike Bantel1, M Lienhard Schmitz, Armin Raible, Michael Gregor, Klaus Schulze-Osthoff.   

Abstract

Glucocorticoid resistance is a serious clinical problem in chronic inflammatory diseases, because many patients with rheumatoid arthritis, asthma, or Crohn's disease fail to respond to steroid treatment. The molecular mechanisms underlying this unresponsiveness, however, are completely unknown. The effects of steroids are largely mediated by the interference of the glucocorticoid receptor (GR) with proinflammatory transcription factors. In the present study, we therefore investigated the activation of the transcription factors nuclear factor-kappaB (NF-kappaB), activator protein-1 (AP-1), and the upstream kinases p38 and c-Jun N-terminal kinase (JNK) in steroid-sensitive and steroid-resistant patients with Crohn's disease. We demonstrated that steroid-sensitive and steroid-resistant patients reveal a remarkably different cellular activation pattern of these proinflammatory mediators. In steroid-sensitive patients, activation of NF-kappaB, AP-1, p38, and JNK was mainly found in lamina propria macrophages. In contrast, steroid-resistant patients revealed activation of all these mediators mostly in epithelial cells. The functional interference of the proinflammatory mediators with the glucocorticoid response was supported by reporter gene assays. Expression of NF-kappaB and, interestingly, also JNK1 and p38 inhibited the activity of the GR. Thus, our results suggest that steroid resistance is associated with increased epithelial activation of stress-activated protein kinases and NF-kappaB, which might inhibit the anti-inflammatory action of a limited number of GRs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223450     DOI: 10.1096/fj.02-0223fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  31 in total

1.  The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis.

Authors:  Kiran Assi; Rex Pillai; Antonio Gómez-Muñoz; David Owen; Baljinder Salh
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Choosing Therapy on the Basis of Disease Classifications in Inflammatory Bowel Disease.

Authors:  Maria T. Abreu
Journal:  Curr Treat Options Gastroenterol       Date:  2004-06

3.  Basal p38 mitogen-activated protein kinase regulates unliganded glucocorticoid receptor function in airway smooth muscle cells.

Authors:  Belaid Bouazza; Manel Debba-Pavard; Yassine Amrani; Lauren Isaacs; Danielle O'Connell; Sara Ahamed; Danielle Formella; Omar Tliba
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

4.  Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases.

Authors:  Belaid Bouazza; Kateryna Krytska; Manel Debba-Pavard; Yassine Amrani; Richard E Honkanen; Jennifer Tran; Omar Tliba
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

Review 5.  The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis.

Authors:  Jongdae Lee; Jose M Gonzales-Navajas; Eyal Raz
Journal:  Semin Immunopathol       Date:  2007-11-20       Impact factor: 9.623

Review 6.  Role of dual specificity phosphatases in biological responses to glucocorticoids.

Authors:  Andrew R Clark; Joana R S Martins; Carmen R Tchen
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

Review 7.  p38(MAPK): stress responses from molecular mechanisms to therapeutics.

Authors:  Lydia R Coulthard; Danielle E White; Dominic L Jones; Michael F McDermott; Susan A Burchill
Journal:  Trends Mol Med       Date:  2009-08-06       Impact factor: 11.951

Review 8.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 9.  Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.

Authors:  E G Quetglas; A Armuzzi; S Wigge; G Fiorino; L Barnscheid; M Froelich; Silvio Danese
Journal:  Eur J Clin Pharmacol       Date:  2015-05-27       Impact factor: 2.953

10.  Influence of NFkappaB inhibitors on IL-1beta-induced chemokine CXCL8 and -10 expression levels in intestinal epithelial cell lines: glucocorticoid ineffectiveness and paradoxical effect of PDTC.

Authors:  Yeruva Sunil; Giuliano Ramadori; Dirk Raddatzc
Journal:  Int J Colorectal Dis       Date:  2010-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.